AbbVie Inc. (ABBV)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
107.54+1.44 (+1.36%)
At close: 4:02PM EDT
| Previous close | 106.10 |
| Open | 106.39 |
| Bid | 107.42 x 1300 |
| Ask | 107.50 x 800 |
| Day's range | 106.05 - 107.72 |
| 52-week range | 78.66 - 113.41 |
| Volume | 5,903,250 |
| Avg. volume | 7,442,741 |
| Market cap | 189.79B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 39.54 |
| EPS (TTM) | 2.72 |
| Earnings date | 30 Apr 2021 |
| Forward dividend & yield | 5.20 (4.84%) |
| Ex-dividend date | 14 Apr 2021 |
| 1y target est | 122.17 |
- Motley Fool
Better Value Stock: AbbVie or Viatris?
AbbVie (NYSE: ABBV) and Viatris (NASDAQ: VTRS) -- especially stand out due to their attractive valuations. Which is the better value stock? You might think that neither AbbVie nor Viatris qualifies as value stocks based on their trailing-12-month price-to-earnings (P/E) ratios.
- Zacks
Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes
FDA delays decision on Pfizer (PFE), AbbVie (ABBV) and Lilly's (LLY) filings for JAK inhibitor candidates. AstraZeneca's (AZN) COVID-19 vaccine troubles continue.
- Zacks
The Zacks Analyst Blog Highlights: ServiceNow, AbbVie and Apple
The Zacks Analyst Blog Highlights: ServiceNow, AbbVie and Apple
© 2021 Verizon Media. All rights reserved.
